Living meta-analysis and evidence synthesis of therapies for COVID-19

click on circles to display study description...

Rashad (CLARI vs SoC), 2021

clarithromycine (n=99) vs. standard of care (n=99)

randomized controlled trial   some concerns about risk of bias

Studied treatment

clarithromycin
500mg /12 h for 7 days

Control treatment

standard of care

3 arms azithromycin, clarithromycin or standard of care

Patients

COVID-19 mild to moderate

Method

open-label

1 centre, Egypt

Remark